Diponed Bio is an India-based regenerative medicine and advanced therapy company developing PRP/PRFM medical devices, stem-cell-based therapeutics, and non-viral cell & gene therapy (CGT) platforms for clinical translation.
The company focuses on platelet-derived biologics, autologous and allogeneic cell therapies (MSC, MNC, VSEL, CIK), and exosome-based regenerative products, addressing unmet needs in orthopedics, chronic wound care, inflammation, aesthetics, oncology support, and tissue regeneration.
Diponed integrates device innovation, GMP-aligned biologics manufacturing, clinical protocols, and translational research, enabling scalable bench-to-bedside deployment within India's regulatory framework. Its portfolio includes clinician-ready regenerative kits, cellular therapeutics, and biologic formulations, supported by clinical data, hospital collaborations, and multicentric studies.
Beyond product development, Diponed contributes to the advanced therapy ecosystem through preclinical research services, regulatory-aligned development programs, and physician education, positioning the company as a full-stack regenerative medicine and ATMP platform.
To be a global leader in point-of-care regenerative medicine and diagnostics, enabling every healthcare provider to offer advanced, affordable, and personalized care through biologics and cellular innovations.
To accelerate healing and improve clinical outcomes by delivering accessible, science-backed regenerative and diagnostic solutions for real-world clinical practice.
To meet unmet medical and healthcare needs across the globe through innovation, science, and modern technologies.
We are ISO: 17025 certified, cGMP compliant, and FDA registered company, manufacturing products that meet highest quality standards. We have a state-of-the-art, in-house laboratory, which is well-equipped with latest in technological equipment, and highly experienced scientists for designing advanced formulation and manufacturing novel products. We are committed to highest product quality and ensure that product testing occurs at every stages of the manufacturing for consistency and quality.
Diponed Bio, India regenerative medicine, PRP PRFM devices, stem cell therapy India, cell therapy MSC MNC VSEL CIK, non-viral gene therapy, CGT platforms, ATMP India, Advanced Therapy Medicinal Products, exosome biologics, platelet-rich plasma, mesenchymal stem cells, autologous cell therapy, allogeneic cell therapy, GMP biologics manufacturing, translational medicine India, orthopedic regenerative therapy, chronic wound care, inflammation treatment, aesthetics regenerative medicine, oncology supportive care, tissue regeneration, clinician-ready regenerative kits, cellular therapeutics, biologic formulations, hospital collaborations India, multicentric studies, preclinical research services, regulatory-aligned development, physician education regenerative medicine, biotechnology India, point-of-care biologics, molecular diagnostics, bench-to-bedside deployment, India regulatory framework, ISO 17025 certified, cGMP compliant, FDA registered company, Crunchbase Diponed Bio, Tracxn India regenerative medicine, LinkedIn cellular therapy, BiopharmIQ ATMP platform, Startup India biotechnology